The success of AAV in vivo experiments is highly dependent on the type of serotype and promoters chosen during vector construction.
SIRION Biotech offers a unique AAV plasmid portfolio to facilitate highly targeted in vivo AAV applications for a multitude of indications.
- Neuroscience & Ophthalmology
- Sceletal Muscle & Cardio-Vascular Reserach
- Liver Research